Physicians’ attitude towards selection of second line therapy with nilotinib and dasatinib in chronic myeloid leukemia patients

We investigated factors that physicians consider of most importance in the selection of second line tyrosine kinase inhibitors treatments (TKIs) in chronic myeloid leukemia patients (CML). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12955-017-0788-4) contains supp...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Health Qual Life Outcomes
Main Authors: Breccia, Massimo, Baccarani, Michele, Rosti, Gianantonio, Cottone, Francesco, Cannella, Laura, Guilhot, François, Vignetti, Marco, Efficace, Fabio
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2017
Assuntos:
Letter to the Editor
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5648464/
https://ncbi.nlm.nih.gov/pubmed/29047379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12955-017-0788-4
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares